![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 44, 46035-46045, October 29, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






**

From the
Departments of
Microbiology and **Pediatrics, University of Virginia Health System, Charlottesville, Virginia 22908 and the ¶School of Biological Sciences, University of Liverpool, Liverpool L69 7ZB, United Kingdom
Fanconi anemia (FA) is an autosomal recessive disease of cancer susceptibility. FA cells exhibit a characteristic hypersensitivity to DNA cross-linking agents. The molecular mechanism for the disease is unknown as few of the FA proteins have functional motifs. Several post-translational modifications of the proteins have been described. We and others (Qiao, F., Moss, A., and Kupfer, G. M. (2001) J. Biol. Chem. 276, 2339123396 and Futaki, M., Watanabe, S., Kajigaya, S., and Liu, J. M. (2001) Biochem. Biophys. Res. Commun. 281, 347351) have reported that the FANCG protein (Fanconi complementation group G) is phosphorylated. We show that in an in vitro kinase reaction FANCG is radioactively labeled. Mass spectrometry analysis detected a peptide containing phosphorylation of serine 7. Using PCR-mediated site-directed mutagenesis we mutated serine 7 to alanine. Only wild-type FANCG cDNA fully corrected FA-G mutant cells. We also tested the effect of human wild-type FANCG in Chinese hamster ovary cells in which the FANCG homologue is mutant. Human FANCG complemented these cells, whereas human FANCG(S7A) did not. Unexpectedly, FANCG(S7A) bound to and stabilized the endogenous forms of the FANCA and FANCC proteins in the FA-G cells. FANCG(S7A) aberrantly localized to globules in chromatin and did not abrogate the internuclear bridges seen in the FA-G mutant cells. Phosphorylation of serine 7 in FANCG is functionally important in the FA pathway.
Received for publication, July 22, 2004 , and in revised form, August 2, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
|| Supported by a Grant from Northwest Cancer Research Fund (UK).

To whom correspondence should be addressed. E-mail: gk9{at}virginia.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Alpi, F. Langevin, G. Mosedale, Y. J. Machida, A. Dutta, and K. J. Patel UBE2T, the Fanconi Anemia Core Complex, and FANCD2 Are Recruited Independently to Chromatin: a Basis for the Regulation of FANCD2 Monoubiquitination Mol. Cell. Biol., December 15, 2007; 27(24): 8421 - 8430. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stone, A. Sobeck, M. van Kogelenberg, B. de Graaf, H. Joenje, J. Christian, and M. E. Hoatlin Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9 Genes Cells, July 1, 2007; 12(7): 841 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kowal, A. M. Gurtan, P. Stuckert, A. D. D'Andrea, and T. Ellenberger Structural Determinants of Human FANCF Protein That Function in the Assembly of a DNA Damage Signaling Complex J. Biol. Chem., January 19, 2007; 282(3): 2047 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taniguchi and A. D. D'Andrea Molecular pathogenesis of Fanconi anemia: recent progress Blood, June 1, 2006; 107(11): 4223 - 4233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |